Related Experiment Video
Updated: Aug 8, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Aureobasidium pullulans keratitis
Anita Panda1, Hrishikesh Das, Manorama Deb
1Department of Ophthalmology, BP Koirala Institute of Health Sciences, Dharan, Nepal. anitap2001@yahoo.com
Background:
Corneal ulcer caused by Aureobasidium pullulans is considered to be a rare entity. So far very few reports have appeared in the world literature and the authors' hospital is the first to report from Nepal. Although A. pullulans is regarded as a contaminant, it should be considered as a pathogen if isolated from corneal ulcer specimen with clinical signs of infection and with growth of the organism on two or more culture media or growth in one medium with consistent direct microscopy findings or growth of the same organism on repeated corneal scrapings. In the present study, a series of proven cases of A. pullulans corneal ulcers at a tertiary eye care centre of Eastern Nepal is reported.
Methods:
A retrospective analysis of stored data of microbiological and clinical cases of corneal ulcer was carried out. All consecutive patients (447 patients) with presumed microbial keratitis from 1 August 1998 to 31 July 2001 were evaluated with regards to clinical details, microbiological examination and management.
Results:
Of 200 fungal organisms isolated from the cultures, 25 were identified as A. pullulans. These ulcers showed negligible improvement to topical natamycin and required either topical fluconazole or topical itraconazole in all along with systemic intravenous fluconazole in eight patients. Of 25 eyes, 22 responded well to antifungal therapy and 2 required therapeutic penetrating keratoplasty. One patient was lost to follow up for 3 months and revealed phthisis bulbi on subsequent examination.
Conclusions:
Aureobasidium pullulans corneal infection should be considered as a cause of keratomycosis.
Insights
Aureobasidium pullulans causes rare corneal ulcers, often mistaken for contaminants. This study confirms its role as a pathogen in keratomycosis, requiring specific antifungal treatments for effective management.
Area of Science:
- Ophthalmology
- Mycology
- Infectious Diseases
Background:
- Corneal ulcers caused by Aureobasidium pullulans are rare, with limited global literature.
- This study reports the first cases from Nepal, highlighting the need to recognize A. pullulans as a potential pathogen in corneal infections.
- Criteria for identifying A. pullulans as a pathogen include consistent isolation from corneal specimens with clinical signs of infection.
Purpose of the Study:
- To report a series of proven cases of Aureobasidium pullulans corneal ulcers.
- To evaluate the clinical presentation, microbiological findings, and treatment outcomes of A. pullulans keratitis.
- To establish A. pullulans as a significant cause of keratomycosis.
Main Methods:
- Retrospective analysis of clinical and microbiological data from 447 patients with presumed microbial keratitis.
- Evaluation of corneal ulcer cases between August 1998 and July 2001.
- Identification of fungal organisms from corneal ulcer specimens and assessment of treatment responses.
Main Results:
- Aureobasidium pullulans was identified in 25 out of 200 fungal isolates from corneal ulcers.
- Topical natamycin was ineffective; topical fluconazole or itraconazole, with systemic fluconazole in some cases, were required.
- 22 out of 25 affected eyes responded well to antifungal therapy, while 2 required therapeutic penetrating keratoplasty.
Conclusions:
- Aureobasidium pullulans should be recognized as a causative agent of keratomycosis.
- Specific antifungal agents like fluconazole and itraconazole are effective in treating A. pullulans corneal infections.
- Prompt and appropriate antifungal therapy is crucial for managing A. pullulans keratitis and preventing severe visual outcomes.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Staphylococcal Skin Infections
Microbiome of the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
